Johnson & Johnson

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.

CEO

Joaquin Duato

CEOJoaquin Duato

Employees

131,900

Employees131,900

Headquarters

New Brunswick, New Jersey

HeadquartersNew Brunswick, New Jersey

Founded

1887

Founded1887

Employees

131,900

Employees131,900

JNJ Key Statistics

Market cap

353.83B

Market cap353.83B

Price-Earnings ratio

19.03

Price-Earnings ratio19.03

Dividend yield

3.20%

Dividend yield3.20%

Average volume

9.50M

Average volume9.50M

High today

—

High today—

Low today

—

Low today—

Open price

$149.37

Open price$149.37

Volume

1.05K

Volume1.05K

52 Week high

$175.97

52 Week high$175.97

52 Week low

$143.13

52 Week low$143.13

JNJ News

Yahoo Finance 19h

Cidara buys back rights to flu therapy from J&J for $85m - Yahoo Finance

Cidara Therapeutics has entered into a definitive agreement with Johnson & Johnson (J&) to buy back the rights to its influenza therapy, CD388. Cidara will pay...

Simply Wall St 24h

Johnson & Johnson's Dividend Will Be Increased To $1.24

Johnson & Johnson (NYSE:JNJ) has announced that it will be increasing its dividend from last year's comparable payment on the 4th of June to $1.24. This will ta...

TipRanks 1d

LLY vs. JNJ: Which Big Pharma Stock Is Better? - TipRanks.com - TipRanks

In this piece, I evaluated two big pharma stocks, Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ), using TipRanks’ Comparison Tool below. A closer look su...

Analyst ratings

57%

of 23 ratings

Buy

43.5%

Hold

56.5%

Sell

More JNJ News

TipRanks 2d

Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M

Cidara Therapeutics (CDTX) announced that it has entered into a definitive agreement with Johnson & Johnson (JNJ) to reacquire the exclusive global development...

Yahoo Finance 2d

The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson - Yahoo Finance

For Immediate Release Chicago, IL – April 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...

Yahoo Finance 4d

Johnson & Johnson Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might aff...

Seeking Alpha 6d

J&J and Kenvue ordered to pay $45M in latest talc-related cancer claim

A panel of jurors in Chicago ordered Johnson & Johnson (NYSE:JNJ) and its consumer care spinoff Kenvue (NYSE:KVUE) to pay $45M to the family of an Illinois resi...

TipRanks 7d

Johnson & Johnson Notches Up After Talc Win

One of the biggest problems for Johnson & Johnson (NYSE:JNJ) in the last decade or so has been talc. This powder, which many swore by until a potential link bet...

Seeking Alpha 7d

Johnson & Johnson wins trial over talc-related cancer claim in Florida

A jury in Florida found that Johnson & Johnson's (NYSE:JNJ) talc-based baby powder did not cause cancer in a woman in the latest trial to proceed after the comp...

Benzinga 7d

Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert

Loading... Loading... The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson...